Cargando…
Access to Cancer Drugs in Canada
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600617/ https://www.ncbi.nlm.nih.gov/pubmed/36290875 http://dx.doi.org/10.3390/curroncol29100598 |
| _version_ | 1784816887512694784 |
|---|---|
| author | Wheatley-Price, Paul |
| author_facet | Wheatley-Price, Paul |
| author_sort | Wheatley-Price, Paul |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9600617 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | MDPI |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96006172022-10-27 Access to Cancer Drugs in Canada Wheatley-Price, Paul Curr Oncol Editorial MDPI 2022-10-12 /pmc/articles/PMC9600617/ /pubmed/36290875 http://dx.doi.org/10.3390/curroncol29100598 Text en © 2022 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Editorial Wheatley-Price, Paul Access to Cancer Drugs in Canada |
| title | Access to Cancer Drugs in Canada |
| title_full | Access to Cancer Drugs in Canada |
| title_fullStr | Access to Cancer Drugs in Canada |
| title_full_unstemmed | Access to Cancer Drugs in Canada |
| title_short | Access to Cancer Drugs in Canada |
| title_sort | access to cancer drugs in canada |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600617/ https://www.ncbi.nlm.nih.gov/pubmed/36290875 http://dx.doi.org/10.3390/curroncol29100598 |
| work_keys_str_mv | AT wheatleypricepaul accesstocancerdrugsincanada |